Doctors Note Logo

Published on: 8/18/2026

The Science of Brain Scans: How Neuroinflammation Proves Fibromyalgia Is Real

Brain imaging research using PET scans has found widespread glial cell activation, a hallmark of neuroinflammation, in people with fibromyalgia, providing objective biological evidence that the condition is a real neurological disorder rather than an imagined or purely psychological one. Studies from teams at Harvard and Karolinska Institutet documented elevated translocator protein levels in the cortex that tracked with fatigue severity, while functional scans show amplified pain processing in the insula, thalamus, and anterior cingulate cortex. These scans are still research tools rather than routine diagnostic tests, and there are several important factors to consider before applying them to your own case, so see below to understand more. Because fibromyalgia symptoms overlap heavily with thyroid disorders, autoimmune disease, sleep apnea, and vitamin deficiencies, getting clear on your specific pattern of pain, fatigue, and brain fog is the practical first step toward validation and treatment. A free, instant, online symptom check can help you organize what you are feeling and identify which specialist is best positioned to take you seriously.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

The Science of Brain Scans: How Neuroinflammation Proves Fibromyalgia Is Real

Fibromyalgia has long been misunderstood as a subjective pain disorder without clear physical markers. Recent advances in brain imaging, however, are changing that narrative. Cutting-edge studies using PET (positron emission tomography) scans provide concrete evidence of neuroinflammation—specifically microglial activation—in people with fibromyalgia. This growing body of research helps validate fibromyalgia as a genuine neurological condition and opens doors to targeted treatments.

Understanding Neuroinflammation and Microglia

What is neuroinflammation?
Neuroinflammation is the brain’s immune response to injury, infection or chronic stress. Unlike acute inflammation in your knee or skin, neuroinflammation involves resident immune cells in the brain.

Role of microglia
Microglia are the central nervous system’s “first responders.” In a healthy brain, they clean up debris and support neurons. When activated, they release signaling molecules (cytokines) that can become chronic, altering pain processing and mood regulation.

Why this matters for fibromyalgia
Fibromyalgia patients often experience widespread pain, fatigue and “fibro fog.” If microglia remain in a heightened state, they can sensitize neural pain pathways, making ordinary sensations painful—a phenomenon known as central sensitization.

PET Scan Evidence of Neuroinflammation

Researchers use specialized PET tracers that bind to proteins expressed by activated microglia. The most common tracer, [^11C]PBR28, attaches to the translocator protein (TSPO), which is upregulated in neuroinflammation.

Key studies:

National Institutes of Health (NIH), 2018
– Compared 20 fibromyalgia patients with healthy controls
– Found a 20–30% increase in TSPO binding in the insula, cingulate cortex and somatosensory regions
– Correlated higher tracer uptake with greater pain severity

University of Michigan, 2020
– Used next-generation TSPO tracers for better resolution
– Demonstrated elevated microglial activation in the prefrontal cortex, a region involved in pain modulation and emotional processing
– Linked neuroinflammation levels to fatigue and cognitive symptoms

European Multicenter Study, 2022
– Pooled data from five PET centers across Europe
– Confirmed reproducible patterns of increased TSPO signal in fibromyalgia versus rheumatoid arthritis and healthy groups
– Showed that microglial activation is not a by-product of general pain but a distinct feature of fibromyalgia

These PET scan evidence studies are critical because they:

  1. Objectively measure microglia neuroinflammation.
  2. Reveal consistent brain patterns unique to fibromyalgia.
  3. Demonstrate a biological basis for patients’ symptoms.

What This Means for Diagnosis and Treatment

  1. Validation of Fibromyalgia
    Neuroinflammation seen on PET scans provides undeniable, biological proof that fibromyalgia is not “all in the head.” It’s rooted in real, measurable changes in brain immune activity.

  2. Potential Biomarkers
    Elevated TSPO binding could one day serve as a biomarker, helping doctors distinguish fibromyalgia from other chronic pain syndromes.

  3. Targeted Therapies
    – Anti-inflammatory drugs that cross the blood-brain barrier (e.g., minocycline)
    – Microglia-modulating agents under development
    – Non-drug approaches like low-frequency transcranial magnetic stimulation (TMS) aimed at reducing neuroinflammation

  4. Personalized Medicine
    Ongoing PET studies may allow physicians to tailor treatments based on each patient’s specific brain inflammation profile.

Taking Charge of Your Health

If you suspect fibromyalgia, be proactive:

  • Track your symptoms: pain intensity, sleep quality, fatigue and mood.
  • Discuss PET scan findings with your doctor if neuroinflammation is a concern.
  • Explore multidisciplinary approaches: medications, physical therapy, cognitive behavioral therapy and lifestyle modifications (exercise, stress management).

You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help organize and clarify your symptoms before your appointment.

Practical Tips for Managing Neuroinflammation

  1. Nutrition
    – Anti-inflammatory diet: rich in omega-3 fatty acids (salmon, flaxseed), colorful fruits and vegetables.
    – Limit processed foods, refined sugars and excessive caffeine.

  2. Exercise
    – Gentle, regular movement (walking, swimming, yoga) can help dampen microglial activation.
    – Start slow and increase duration/intensity as tolerated.

  3. Stress Reduction
    – Mindfulness meditation, guided imagery and breathing exercises may lower inflammatory signals in the brain.
    – Consistent sleep hygiene: maintain a stable sleep schedule; create a calm bedtime routine.

  4. Medication and Supplements
    – Work with your doctor to consider drugs that target central inflammation.
    – Discuss supplements like curcumin, resveratrol or N-acetylcysteine, which have shown promise in reducing neuroinflammation in early research.

Looking Ahead

As PET scan technology continues to evolve, we expect even clearer maps of microglia neuroinflammation in fibromyalgia. These insights will not only solidify fibromyalgia’s status as a bona fide neurological disorder but also accelerate the development of therapies aimed specifically at calming overactive microglia.

When to Seek Professional Help

If you experience any of the following, please speak to a doctor immediately:

  • Sudden, severe pain unresponsive to usual treatments
  • Neurological symptoms like sudden weakness or vision changes
  • Signs of serious infection, high fever or confusion

For persistent fatigue, chronic widespread pain or cognitive difficulties, consult a healthcare provider experienced in fibromyalgia and neuroinflammation.


Understanding the role of microglia and neuroinflammation through PET scan evidence is a major step forward in fibromyalgia research. It transforms the way we view and treat this condition—no longer as an invisible illness, but as one with clear, objective markers in the brain. If fibromyalgia affects you or a loved one, remember that real science is on your side. Don’t hesitate to take the first step: a free, online symptom check, using the doctor approved Ubie Symptom Checker can help you organize your concerns and prepare for a productive discussion with your healthcare team. And always, speak to a doctor about anything that feels life threatening or seriously worrisome.

(References)

  • * Sánchez del Río-González M. [Chronic migraine: pathophysiology]. Rev Neurol. 2012 Apr 10;54 Suppl 2:S13-9. PMID: 22532238.

  • * Sumpton JE, Moulin DE. Fibromyalgia. Handb Clin Neurol. 2014;119:513-27. doi: 10.1016/B978-0-7020-4086-3.00033-3. PMID: 24365316.

  • * Gomez-Arguelles JM, Maestu-Unturbe C, Gomez-Aguilera EJ. [Neuroimaging in fibromyalgia]. Rev Neurol. 2018 Nov 16;67(10):394-402. PMID: 30403283.

  • * Kim PS, Fishman MA. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. Curr Pain Headache Rep. 2020 Aug 26;24(10):64. doi: 10.1007/s11916-020-00898-0. Epub 2020 Aug 26. PMID: 32845365.

  • * Atta AA, Ibrahim WW, Mohamed AF, Abdelkader NF. Microglia polarization in nociplastic pain: mechanisms and perspectives. Inflammopharmacology. 2023 Jun;31(3):1053-1067. doi: 10.1007/s10787-023-01216-x. Epub 2023 Apr 17. PMID: 37069462; PMCID: PMC10229465.

  • * Giorgi V, Bazzichi L, Batticciotto A, Pellegrino G, Di Franco M, Sirotti S, Atzeni F, Alciati A, Salaffi F, Sarzi Puttini P. Fibromyalgia: one year in review 2023. Clin Exp Rheumatol. 2023 Jun;41(6):1205-1213. doi: 10.55563/clinexprheumatol/257e99. Epub 2023 Jun 28. PMID: 37378487.

  • * Di Carlo M, Bianchi B, Salaffi F, Pellegrino G, Iannuccelli C, Giorgi V, Sarzi-Puttini P. Fibromyalgia: one year in review 2024. Clin Exp Rheumatol. 2024 Jun;42(6):1141-1149. doi: 10.55563/clinexprheumatol/mbyi1n. Epub 2024 Apr 10. PMID: 38607678.

  • * García-Domínguez M. Fibromyalgia and Inflammation: Unrevealing the Connection. Cells. 2025 Feb 13;14(4). doi: 10.3390/cells14040271. Epub 2025 Feb 13. PMID: 39996743; PMCID: PMC11853252.

  • * Iannuccelli C, Favretti M, Dolcini G, Di Carlo M, Pellegrino G, Bazzichi L, Atzeni F, Lucini D, Varassi G, Leoni MLG, Fornasari DMM, Conti F, Salaffi F, Sarzi-Puttini P, Di Franco M. Fibromyalgia: one year in review 2025. Clin Exp Rheumatol. 2025 Jun;43(6):957-969. doi: 10.55563/clinexprheumatol/buhd2z. Epub 2025 Jun 3. PMID: 40470564.

  • * Benjamin NZY, Parekh RS, Inban P, Sakthi S, Tekuru Y, Prajjwal P, John J, Sharma R. Fibromyalgia: Advances in pathophysiology, diagnostic biomarkers, genetic insights, multisystemic involvement, and treatment updates and multidisciplinary interventions. Dis Mon. 2025 Sep;71(9):101965. doi: 10.1016/j.disamonth.2025.101965. Epub 2025 Jun 29. PMID: 40582925.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.